Skip to main content
SpringerLink
Log in

Positive Effects of a Sufficient Pre-fracture Serum Vitamin D Level on the Long-Term Survival of Hip Fracture Patients in Finland: A Minimum 11-Year Follow-Up

  • Original Research Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Background

Several studies have shown that the mortality of elderly hip fracture patients is higher than that in the general population, and is higher in male than in female hip fracture patients.

Objective

The objective of this study was to investigate factors affecting overall mortality at a minimum of 11 years following a new hip fracture.

Methods

The sex, age, pre-fracture serum 25-hydroxyvitamin D level, American Society of Anesthesiologists physical status classification (ASA class), 1- to 12-month mortality, and 2- to 11-year mortality of hip fracture patients were collected. The use of anti-osteoporotic medication and prescribed calcium and vitamin D supplements during the first 3 post-operative years were checked. The survival of the patients was analyzed using both the Bayesian multivariate analysis and the life table method.

Results

The mean age of females at the time of the index hip fracture was 80.5 years and of males was 73 years. The protective factors were age <80 years; ASA class 1–2; serum 25-hydroxyvitamin level ≥50 nmol/L; post-fracture use of calcium and vitamin D supplementation; post-fracture concomitant use of calcium and vitamin D supplementation and anti-osteoporotic drugs; and male sex. The excess mortality was higher among women than men. Survival was highest among patients with a vitamin D level of ≥50 nmol/L. Post-fracture concomitant use of calcium and vitamin D and anti-osteoporotic drugs was positively associated with survival.

Conclusion

Our results indicate a positive relationship between a sufficient pre-fracture vitamin D serum concentration (≥50 nmol/L) and survival, and a potential relationship between reduced mortality and the concomitant post-fracture use of prescribed calcium plus vitamin D supplementation and anti-osteoporotic medication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Haentjens P, Magaziner J, Colon-Emeric CS, et al. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med. 2010;152:380–90.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Abrahamsen B, van Staa T, Ariely R, et al. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int. 2009;20:1633–50.

    Article  CAS  PubMed  Google Scholar 

  3. Diamantopoulos AP, Hoff M, Skoie IM, et al. Short- and long-term mortality in males and females with fragility hip fracture in Norway. A population-based study. Clin Interv Aging. 2013;8:817–23.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Richmond J, Aharonoff GB, Zuckerman JD, et al. Mortality risk after hip fracture. J Orthop Trauma. 2003;17:53–6.

    Article  PubMed  Google Scholar 

  5. Parker MJ, Anand JK. What is the true mortality of hip fractures? Public Health. 1991;105:443–6.

    Article  CAS  PubMed  Google Scholar 

  6. Sernbo I, Johnell O. Consequences of a hip fracture: a prospective study over 1 year. Osteoporos Int. 1993;3:148–53.

    Article  CAS  PubMed  Google Scholar 

  7. Trombetti A, Herrmann F, Hoffmeyer P, et al. Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int. 2002;13:731–7.

    Article  CAS  PubMed  Google Scholar 

  8. Jiang HX, Majumdar SR, Dick DA, et al. Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures. J Bone Miner Res. 2005;20:494–500.

    Article  CAS  PubMed  Google Scholar 

  9. Farahmand BY, Michaelsson K, Ahlbom A, et al. Survival after hip fracture. Osteoporos Int. 2005;16:1583–90.

    Article  PubMed  Google Scholar 

  10. Cree MW, Juby AG, Carriere KC. Mortality and morbidity associated with osteoporosis drug treatment following hip fracture. Osteoporos Int. 2003;14:722–7.

    Article  PubMed  Google Scholar 

  11. Johnell O, Kanis JA, Oden A, et al. Mortality after osteoporotic fractures. Osteoporos Int. 2004;15:38–42.

    Article  CAS  PubMed  Google Scholar 

  12. Magaziner J, Lydick E, Hawkes W, et al. Excess mortality attributable to hip fracture in white women aged 70 years and older. Am J Public Health. 1997;87:1630–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Holmberg S, Conradi P, Kalen R, et al. Mortality after cervical hip fracture. 3002 patients followed for 6 years. Acta Orthop Scand. 1986;57:8–11.

    Article  CAS  PubMed  Google Scholar 

  14. Vaseenon T, Luevitoonvechkij S, Wongtriratanachai P, et al. Long-term mortality after osteoporotic hip fracture in Chiang Mai, Thailand. J Clin Densitom. 2010;13:63–7.

    Article  PubMed  Google Scholar 

  15. Vestergaard P, Rejnmark L, Mosekilde L. Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications. Osteoporos Int. 2007;18:1583–93.

    Article  CAS  PubMed  Google Scholar 

  16. Schroder HM, Erlandsen M. Age and sex as determinants of mortality after hip fracture: 3,895 patients followed for 2.5-18.5 years. J Orthop Trauma. 1993;7:525–31.

    Article  CAS  PubMed  Google Scholar 

  17. von Friesendorff M, Besjakov J, Åkesson K. Long-term survival and fracture risk after hip fracture: a 22-year follow-up in women. J Bone Miner Res. 2008;23:1832–41.

    Article  PubMed  Google Scholar 

  18. Hu F, Jiang C, Shen J, et al. Preoperative predictors for mortality following hip fracture surgery: a systematic review and meta-analysis. Injury. 2012;43:676–85.

    Article  PubMed  Google Scholar 

  19. Diamantopoulos AP, Hoff M, Hochberg M, et al. Predictors of short- and long-term mortality in males and females with hip fracture—a prospective observational cohort study. PLOS One. 2013;8:e78169.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Nurmi-Lüthje I, Sund R, Juntunen M, et al. Post-hip fracture use of prescribed calcium plus vitamin D or vitamin D supplements and anti-osteoporotic drugs is associated with lower mortality: a nationwide study in Finland. J Bone Miner Res. 2011;26:1845–53.

    Article  PubMed  Google Scholar 

  21. Bolland MJ, Grey AB, Gamble GD, et al. Effect of osteoporosis treatment on mortality: a meta-analysis. J Clin Endocrin Metab. 2010;95:1174–81.

    Article  CAS  Google Scholar 

  22. Nurmi I, Kaukonen JP, Lüthje P, et al. Half of the patients with an acute hip fracture suffer from hypovitaminosis D: a prospective study in southeastern Finland. Osteoporos Int. 2005;16:2018–24.

    Article  CAS  PubMed  Google Scholar 

  23. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22:477–501.

    Article  CAS  PubMed  Google Scholar 

  24. Hossein-nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc. 2013;88:720–55.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Sankar A, Johnson SR, Beattie WS, et al. Reliability of the American Society of Anesthesiologists physical status scale in clinical practice. Br J Anaesth. 2014;113:424–32.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Lüthje P, Nurmi-Lüthje I, Kaukonen JP, et al. Undertreatment of osteoporosis following hip fracture in the elderly. Arch Gerontol Geriatr. 2009;49:153–7.

    Article  PubMed  Google Scholar 

  27. Nurmi-Lüthje I, Lüthje P, Kaukonen JP, et al. Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis. Drugs Aging. 2009;26:409–21.

    Article  PubMed  Google Scholar 

  28. Lüthje P, Helkamaa T, Kaukonen JP, et al. A long-term follow-up of 221 hip fracture patients in southeastern Finland: analysis of survival and prior or subsequent fractures. Arch Gerontol Geriatr. 2012;54:e294–9.

    Article  PubMed  Google Scholar 

  29. Richmond J, Aharonoff GB, Zuckerman JD, et al. Mortality risk after hip fracture. J Orthop Trauma. 2003;17:53–6.

    Article  PubMed  Google Scholar 

  30. Tsuboi M, Hasegawa Y, Suzuki S, et al. Mortality and mobility after hip fracture in Japan: a ten-year follow-up. J Bone Joint Surg Br. 2007;89-B:461–6.

  31. Kannegaard PN, van der Mark S, Eiken P, et al. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing. 2010;39:203–9.

    Article  PubMed  Google Scholar 

  32. Kang HY, Yang KH, Kim YN, et al. Incidence and mortality of hip fracture among the elderly population in South Korea: a population-based study using the national health insurance claims data. BMC Public Health. 2010;10:230.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Wang CB, Lin CF, Liang WM, et al. Excess mortality after hip fracture among the elderly in Taiwan: a nationwide population-based cohort study. Bone. 2013;56:147–53.

    Article  PubMed  Google Scholar 

  34. Nurmi I, Narinen A, Lüthje P, et al. Functional outcome and survival after hip fracture in elderly: a prospective study in 106 consecutive patients. J Orthopaed Traumatol. 2004;4:7–14.

    Article  Google Scholar 

  35. Karagiannis A, Papakitsou E, Dretakis K, et al. Mortality rates of patients with a hip fracture in a southwestern district of Greece: ten-year follow-up with reference to the type of fracture. Calcif Tissue Int. 2006;78:72–7.

    Article  CAS  PubMed  Google Scholar 

  36. Castronuovo E, Pezzotti P, Franzo A, et al. Early and late mortality in elderly patients after hip fracture: a cohort study using administrative health databases in the Lazio region, Italy. BMC Geriatr. 2011;11:37. doi:10.1186/1471-2318-11-37.

    Article  Google Scholar 

  37. Peltola M, Juntunen M, Häkkinen U, et al. A methodological approach for register-based evaluation of cost and outcomes in health care. Ann Med. 2011;43(Suppl 1):S4–13.

    Article  PubMed  Google Scholar 

  38. Kaukonen JP, Lüthje P, Nurmi-Lüthje I, et al. Second hip fracture and patients’ medication after the first hip fracture: a follow-up of 221 hip fracture patients in Finland. Arch Gerontol Geriatr. 2011;52:185–9.

    Article  PubMed  Google Scholar 

  39. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167:1730–7.

    Article  CAS  PubMed  Google Scholar 

  40. Wang L, Song Y, Manson JE, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012;5:819–29.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  41. Virtanen JK, Nurmi T, Voutilainen S, et al. Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland. Eur J Nutr. 2011;50:305–12.

    Article  CAS  PubMed  Google Scholar 

  42. Kilkkinen A, Knekt P, Aro A, et al. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol. 2009;170:1032–9.

    Article  PubMed  Google Scholar 

  43. Lehtonen-Veromaa M, Möttönen T, Leino A, et al. Prospective study on food fortification with vitamin D among adolescent females in Finland: minor effects. Br J Nutr. 2008;100:418–23.

    Article  CAS  PubMed  Google Scholar 

  44. The National FINDIET 2012 Survey. National Institute for Health and Welfare. Report 16/2013. http://urn.fi/URN:ISBN:978-952-245-951-0. Accessed 24 Apr 2015.

  45. Cameron ID, Chen JS, March LM, et al. Hip fracture causes excess mortality owing to cardiovascular and infectious disease in institutionalized older people: a prospective 5-year study. J Bone Miner Res. 2010;4:866–72.

    Google Scholar 

  46. Beaupre LA, Morrish DW, Hanley DA, et al. Oral bisphosphonates are associated with reduced mortality after hip fracture. Osteoporos Int. 2011;22:83–91.

    Article  Google Scholar 

  47. Sambrook PN, Cameron ID, Chen JS, et al. Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study. Osteoporos Int. 2011;22:2551–6.

    Article  CAS  PubMed  Google Scholar 

  48. Lyles KW, Colon-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007;357:1799–809.

    Article  CAS  PubMed  Google Scholar 

  49. Colon-Emeric CS, Mesenbrink P, Lyles KW, et al. Potential mediators of the mortality reduction with zoledronic acid after hip fracture. J Bone Miner Res. 2010;25:91–7.

    Article  CAS  PubMed  Google Scholar 

  50. Huntjens KM, van Geel TA, van den Bergh JP, et al. Fracture liaison service: impact on subsequent nonvertebral fracture incidence and mortality. J Bone Joint Surg Am. 2014;96(4):e29. doi:10.2106/JBJS.L.00223.

  51. Lüthje P, Helkamaa T, Nurmi-Lüthje I, et al. An 8-year follow-up study of 221 consecutive hip fracture patients in Finland: analysis of reoperations and their direct medical costs. Scand J Surg. 2014;103:46–53.

    Article  PubMed  Google Scholar 

  52. National guidelines. Treatment of hip fracture patients. Duodecim. 2006;122:358–379. http://www.kaypahoito.fi. Accessed 13 Sep 2010.

  53. Giversen IM. Time trends of mortality after first hip fractures. Osteoporos Int. 2007;18:721–32.

    Article  CAS  PubMed  Google Scholar 

  54. Rodan G, Reszka A, Golub F, et al. Bone safety of long-term bisphosphonate treatment. Curr Med Res Opin. 2004;20:1291–300.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This manuscript was written and edited by the authors, who take full responsibility for its content.

Compliance with ethical standards

The study was supported by grants from the EVO foundation of the Kymenlaakso and Päijät-Häme healthcare districts. The authors have no conflicts of interest that are directly relevant to the content of this study.

Author information

Authors and Affiliations

  1. Department of Public Health, Hjelt Institute, University of Helsinki, PO Box 41, 00014, Helsinki, Finland

    Ilona Nurmi-Lüthje

  2. Department of Orthopaedics and Traumatology, North Kymi Hospital, Kuusankoski, Finland

    Peter Lüthje

  3. Department of Orthopaedics and Traumatology, Päijät-Häme Central Hospital, Lahti, Finland

    Juha-Pekka Kaukonen

  4. National Institute for Health and Welfare, Helsinki, Finland

    Matti Kataja

Authors
  1. Ilona Nurmi-Lüthje
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Lüthje
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Juha-Pekka Kaukonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Matti Kataja
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ilona Nurmi-Lüthje.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nurmi-Lüthje, I., Lüthje, P., Kaukonen, JP. et al. Positive Effects of a Sufficient Pre-fracture Serum Vitamin D Level on the Long-Term Survival of Hip Fracture Patients in Finland: A Minimum 11-Year Follow-Up. Drugs Aging 32, 477–486 (2015). https://doi.org/10.1007/s40266-015-0267-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-015-0267-8

Keywords

Search

Navigation